News/American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3)

Ketamine Infusion Clinics Treating CRPS and Fibromyalgia Are Using Virtual Assistants to Coordinate Infusion Series and Prior Authorization

VA Research Team·

Ketamine infusion therapy for pain conditions — including complex regional pain syndrome (CRPS), fibromyalgia, refractory neuropathic pain, and post-surgical chronic pain — operates in a distinct administrative environment from ketamine therapy for psychiatric indications. Pain-indication ketamine programs involve multi-session infusion series (typically six infusions over two weeks for initial treatment), diagnostic codes that span neurology, rheumatology, and anesthesiology, and a payer coverage landscape that is evolving but still inconsistent.

Clinics treating these complex pain patients are increasingly turning to virtual assistants to manage the administrative workflows that distinguish pain-indication ketamine from other infusion programs.

CRPS and Fibromyalgia Patient Intake Coordination

Patients presenting to a ketamine infusion clinic for CRPS or fibromyalgia require a comprehensive intake that documents diagnosis history, prior treatment failures, current medications, contraindications to ketamine, and baseline pain and function scores. For CRPS patients in particular, the intake must capture Budapest Criteria documentation and prior sympathetic nerve block or physical therapy records to support medical necessity.

Virtual assistants manage this intake by sending pre-visit questionnaires through the clinic's patient portal, collecting and organizing prior medical records from referring providers, preparing a structured intake summary for the treating anesthesiologist or pain physician, and scheduling the initial consultation appointment based on provider availability. This preparation ensures that the clinical evaluation can focus on treatment planning rather than record gathering.

According to the American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3), incomplete prior treatment documentation is one of the most frequent causes of insurance denial for pain-indication ketamine infusions — making thorough intake coordination a direct revenue protection function.

Infusion Series Scheduling and Coordination

A standard ketamine infusion series for a pain indication involves multiple sessions over a compressed timeframe, with each session requiring confirmed anesthesia or nursing supervision, IV access preparation, and a designated recovery period before discharge. Coordinating a six-session series for multiple concurrent patients — while managing rescheduling requests, insurance authorization confirmations, and pre-session preparation reminders — is a significant scheduling management task.

Virtual assistants build and maintain the infusion series schedule for each patient, send pre-session reminders with preparation instructions (including NPO requirements when applicable), confirm that insurance authorization covers the full series before the first infusion, and manage rescheduling requests without disrupting the treatment series timeline. For clinics running multiple infusion suites, VAs maintain suite utilization dashboards to maximize throughput.

VAS and NRS Pain Outcomes Documentation

Payers that cover ketamine infusions for pain indications typically require documented evidence of treatment response to authorize maintenance infusions or repeat series. The most commonly used outcome measures are the Visual Analog Scale (VAS) and the Numeric Rating Scale (NRS), both of which must be collected at baseline, after each infusion session, and at defined follow-up intervals.

Virtual assistants coordinate outcomes data collection by sending VAS and NRS questionnaires through the patient portal before and after each infusion, compiling scores into a longitudinal outcomes report, and flagging patients who are not achieving adequate pain reduction for clinical review. This outcomes documentation also supports the clinic's quality improvement reporting and any participation in registry data collection programs.

A 2024 outcomes study published in Regional Anesthesia and Pain Medicine found that ketamine infusion clinics with systematic outcomes tracking reported 40% higher rates of documented treatment response compared to those relying on clinician-reported impressions — a finding with direct implications for insurance authorization outcomes.

Insurance Prior Authorization Documentation

Coverage for ketamine infusions for pain indications is expanding but remains inconsistent. Aetna, Cigna, UnitedHealthcare, and Blue Cross Blue Shield plans each have distinct medical policies governing ketamine coverage for diagnoses like CRPS (ICD-10 G90.5x) and fibromyalgia (M79.7). Successful prior authorization requires a payer-specific documentation strategy, including diagnosis codes, prior treatment failure documentation, and in some cases a literature citation supporting medical necessity.

Virtual assistants trained in ketamine prior authorization build payer-specific authorization packages, submit requests through appropriate channels, track approval status, and draft peer-to-peer request letters when initial submissions are denied. For self-pay clinics, VAs provide patients with insurance appeal letters and documentation packages they can submit independently.

Building a Sustainable Pain Ketamine Practice

Ketamine infusion clinics focused on pain indications face a business model that depends heavily on administrative efficiency — patient series must be scheduled and authorized quickly to maintain utilization, and outcomes data must be collected systematically to support ongoing coverage. Virtual assistants provide the coordination infrastructure that makes this model scalable. Learn how Stealth Agents supports ketamine infusion clinics with specialized virtual assistant services for pain programs.


Sources

  • American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3), Clinical and Administrative Best Practices, 2024
  • Regional Anesthesia and Pain Medicine, Ketamine Infusion Outcomes Tracking and Insurance Authorization, 2024
  • Aetna, Cigna, UnitedHealthcare Clinical Policy Bulletins on Ketamine Infusion for Pain, reviewed 2025